medigraphic.com
ISSN 0138-7103 (Print)

2014, Number 2

<< Back Next >>

Revista del Hospital Psiquiátrico de La Habana 2014; 11 (2)

Deterioration level of adults patients with epilepsy from Havana assisted in salutogenic consultation

González PS, Felipe GMA, Barrios HY, Llanes BY, Montero SRM

Language: Spanish
References: 24
Page:
PDF size: 209.95 Kb.


ABSTRACT

Objective: To determine cognitive deterioration and to identify the association between the presence of cognitive deterioration and psychobiological, biologic and socialdemographic associations.
Methods: An observable explain study of retrospective cohort was carried out on a sample of 216 patients from different municipalities of Havana province that assisted during the period from September, 2011 to December, 2013 to the Salutogenic Consultation from “Joaquin Albarrán” Clinical-Surgical Hospital. An intelligence scale for adults was applied, Wisdom Adult Intelligence Scale (WAIS). The sample was divided into two groups: with and without deterioration. On groups, a search for deterioration relation with medicines, social, biologic and socialdemographic factors was done. Data was processed through SPSS statistical system. Association measures used were Odds Ratio, Fisher´s Exact Probability and Anova Test.
Results: A definite deterioration was presented on 31 % of the patients while a 15, 3% resulted as a possible deterioration. On the biologic factors was relevant that 47 % of the patients with more than a crisis monthly since the beginning of the disease presented deterioration (Fisher p=0.0324) and 50% with partial crisis secondarily generalized presented deterioration (Anova p=0.0014). Between the psychosocial factors, the patients with epilepsy and psychosis presented more deterioration and among the patients related to medicines phenytoin was the pharmacy more related to deterioration.
Conclusion: The high frequency of epilepsy crisis and the use of phenytoin were found as factors to be controlled as possible causes of deterioration on the patient with epilepsy.


REFERENCES

  1. Hermann B, Whitman W, editors. Neurobiological, psychosocial and pharmacological factors underlying interictal psychopathology in epilepsy. New York: Raven Press Ltd; 1991.

  2. González-Pal S, Quintana-Mendoza J, Fabelo-Roche J, Rivero-Lapuente L. Depresión en enfermos con epilepsia y migraña. Psiquiatría.com. 2003; 7(2): Disponible en:http://www.psiquiatria.com/psiquiatria/revista/101/12184/++interactivo

  3. González-Pal S, Mendoza JQ, Roche JF, Palmer LV. Análisis de variables multicausales de la depresión en pacientes con epilepsia. Rev del Hosp Psiq de la Habana [Internet]. 2004; 24 (1): Disponible en: ww.sld.cu/revistas/hph/hph_1_04/hphsu104.htm

  4. González-Pal S, Quintana-Mendoza J, Fabelo-Roche J. Ansiedad en un grupo de pacientes con epilepsia, estudio de variable biológicas y farmacológicas. Psiquiatria.com [Internet]. 2004; (4): Disponible en: www.psiquiatria.com/psiquiatria/revista/132/19770/?++interactivo.

  5. Quintana-Mendoza J, González-Pal S, Rodríguez CG. Wais como instrumento evaluador de deterioro en las Psicosis Epilépticas2004; 8(3): Disponible en:www.psiquiatria.com/psiquiatria/revista/131/16079/?++interactivo.

  6. González-Pal S, Quintana-Mendoza J, Fabelo-Roche J, González-Delgado E, Moré SI. Principales Factores en la epilepsia que inducen al deterioro de funciones. Revista Ecuatoriana de Neurología. 2009;1:69-88.

  7. Campos C. Neuropsicología de le epilepsia ¿Qué factores están implicados? Rev Neurol. 2006;43(1):59-70.

  8. Loring D, Hermann B, Cohen M. Neuropsychological Advocacy and Epilepsy. The Clinical Neuropsychologist.2010;2:417-28.

  9. Commission on classification and terminology of the International League Against Epilepsy (ILAE). Proposal for revised clinical and electroencephalographic classification of epilepsies and epileptic syndromes. Epilepsia1989;30: 389-99.

  10. Wechsller D, editor. La medición de la Inteligencia Adulto. 2da ed. La Habana: Ed. Revolución;1955.

  11. Maestu P, Martín A, Sola R, Ortiz B. Neuropsicología y deterioro cognitivo en la epilepsia. Rev Neurol.1999;28(8):793-8.

  12. Bourgeois B, Prensky A, palkes H. Intelligence in epilepsy: a prospective study in children. Ann Neurol1983;14:438-44.

  13. Tuchman R, Moshé S, Rapin I. Trastornos del neurodesarrollo y epilepsia. Rev Neurol. 2005;40(1):3-10.

  14. Neyens L, Aldenkeamp A, Meinardi H. Prospective follow-up of intellectual development in children with a recent onset of epilepsy. Epilepsy Res.1999;34:85-90.

  15. Hermann B, Seidenberg M. Epilepsy and Cognition. Epilepsy Current2007;7:1-6.

  16. Brown S. Deterioration. Epilepsia. 2006;47(2):19-23.

  17. Fastenau P, Shen J, Dunn D. Neuropsychological predictors of academic underachievement in pediatric epilepsy: moderating roles demographic, seizures, and psichosocial variables. Epilepsia2004;45:1261-72.

  18. Aldenkamp A, Weber B, Overweg-Plandsoen W. Educational underachievement in children with epilepsy: a model to predict the effects of epilepsy on educational achievement. J Child Neurol. 2005; 20:175-80.

  19. González-Pal S, Faure-Vidal A, Quintana-Mendoza J, Fabelo-Roche J, Sánchez M. Disfunción del lóbulo frontal en pacientes con epilepsia y psicosis crónica. Rev Neurol. 1999; 28:219-23.

  20. García-Peñas J, Fournier-DelCastillo C, Dominguez-Carral I. Epilepsia y cognición: el papel de los fármacos antiepilépticos. Rev Neurol. 2014;58(1):537-42.

  21. Perucca E, Kwan P. Overtreatment in epilepsy: how it occurs and how it can be avoided. CNS Drugs2005;19:897-908.

  22. Ortinski P, Meador K. Cognitive side effects of antiepileptic drugs. Epilepsy Behav. 2004;5(Supp 1):S60-5.

  23. Vinayan K. Epilepsy, antiepileptic drugs and educational problems. Indian Pediatr. 2006;43:786-94.

  24. Salinsky M, Spencer D, Oken B, Storzbach D. Effects of oxcarbamazepine and phenytoin on the EEG and cognition in healthy volunteers. Epilepsy Behav. 2004;5:894-902.




2020     |     www.medigraphic.com